CAJ | 학술논문

目的：分析静脉溶栓联合参附注射液治疗急性下壁心肌梗死合并缓慢性心律失常的临床疗效。方法收集2011年1月～2013年1月本院收治的40例急性下壁心肌梗死合并缓慢性心律失常患者临床资料，将患者随机分为研究组与对照组，每组例数均为20例。对照组采取常规治疗，研究组实施静脉溶栓联合参附注射液治疗，最后分析两组患者治疗有效率、心律变化、缓慢心律失常持续时间以及血脂水平变化等。结果研究组总有效率为90.00%，明显高于对照组的75.00%，差异显著，具有统计学意义（P＜0.05）。研究组治疗后心率、缓慢心律失常持续时间、血脂水平变化明显优于对照组，差异显著，具有统计学意义（P＜0.05）。两组患者均无发生明显不良反应。结论静脉溶栓联合参附注射液治疗急性下壁心肌梗死合并缓慢性心律失常，有利于缩短缓慢心律失常的持续时间，提高心室率，降低血脂水平，安全性与有效性显著，值得临床推广。
목적：분석정맥용전연합삼부주사액치료급성하벽심기경사합병완만성심률실상적림상료효。방법수집2011년1월～2013년1월본원수치적40례급성하벽심기경사합병완만성심률실상환자림상자료，장환자수궤분위연구조여대조조，매조례수균위20례。대조조채취상규치료，연구조실시정맥용전연합삼부주사액치료，최후분석량조환자치료유효솔、심률변화、완만심률실상지속시간이급혈지수평변화등。결과연구조총유효솔위90.00%，명현고우대조조적75.00%，차이현저，구유통계학의의（P＜0.05）。연구조치료후심솔、완만심률실상지속시간、혈지수평변화명현우우대조조，차이현저，구유통계학의의（P＜0.05）。량조환자균무발생명현불량반응。결론정맥용전연합삼부주사액치료급성하벽심기경사합병완만성심률실상，유리우축단완만심률실상적지속시간，제고심실솔，강저혈지수평，안전성여유효성현저，치득림상추엄。
Objective To analyze the clinical efficacy of intravenous thrombolytic therapy combined with Shenfu injection in the treatment of acute inferior myocardial infarction with bradyarrhythmia. Methods 40 cases' clinical datum of acute inferior myocardial infarction with bradyarrhythmia in our hospital from January 2011 to January 2013 were selected,and they were randomly divided into the control group and the study group, each group had 20 cases. The control group was given conventional therapy,the study group was received intravenous thrombolysis combined with Shenfu injection treatment. The efficiency,rhythm changes, duration of bradyarrhythmia and lipid levels changes of the two groups were analyzed. Results The total effective rate of the study group was 90.00%, which was significantly higher than 75.00%of the control group,there had statistical significance(P<0.05). After the treatment, the rhythm, duration of bradyarrhythmia and lipid levels changes in the study group were significantly better than those in the control group, there had statistical significance(P < 0.05). All the patients in the two groups had no obvious adverse reactions. Conclusion The method of intravenous thrombolysis combined with Shenfu injection in the treatment of acute inferior myocardial infarction with bradyarrhythmia is conducive to shorten the duration of bradyarrhythmia, improve the ventricular rate and lower the blood lipids levels, the safety and effectiveness are significant, and it is worthy for clinical promotion.